AK

Aditya Kalyanrao Patil

Active Director Director DIN 08406104
DIN 08406104 First appointment Mar 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Aditya Kalyanrao Patil

Data last updated:

Aditya Kalyanrao Patil is a Director at Aelmar Pharmaceutical Private Limited (since 2019). The company operates in Pharma. Aelmar Pharmaceutical Private Limited reported revenue of ₹10.6 Lakh (FY 2025).

DIN 08406104
Primary Designation Director
Industry Pharma
First Appointment 29 Mar 2019
Oldest Company Age 7 yrs
Largest company Aelmar Pharmaceutical Private Limited · ₹10.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20192019₹10.6 Lakh (FY 2025)Active

Board colleagues of Aditya Kalyanrao Patil

Directorship timeline

Open interactive timeline →
Aelmar Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Aditya Kalyanrao Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aditya Kalyanrao Patil

Aditya Kalyanrao Patil currently holds 1 directorship: Aelmar Pharmaceutical Private Limited (Director, since 29 Mar 2019, revenue ₹10.6 Lakh (FY 2025)).

Aditya Kalyanrao Patil was first appointed on 29 Mar 2019 as Director at Aelmar Pharmaceutical Private Limited.

The current boards of Aditya Kalyanrao Patil's companies include Abdul Rahil Quadeer Abdul (Aelmar Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available